[CRIPSR-Cas9: A therapeutic strategy for laminopathies?]

Med Sci (Paris). 2023 Nov:39 Hors série n° 1:65. doi: 10.1051/medsci/2023139. Epub 2023 Nov 17.

[Article in French]

Author

Louise Benarroch¹

Affiliation

¹ Sorbonne Université, Inserm, Institut de Myologie, Centre de Recherche en Myologie, Paris, France.

PMID: 37975774
DOI: 10.1051/medsci/2023139

No abstract available

MeSH terms

CRISPR-Cas Systems*
Gene Editing
Humans
Lamin Type A / genetics
Laminopathies*

Substances

Lamin Type A